OKYO Pharma is a clinical-stage biopharmaceutical company focused on developing therapies for inflammatory eye diseases and ocular pain. The company’s programs include candidates for dry eye disease and related ophthalmic conditions.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!